Strong in vitro anticancer activity of copper(ii) and zinc(ii) complexes containing naturally occurring lapachol: cellular effects in ovarian A2780 cells†‡
IF 3.597 Q2 Pharmacology, Toxicology and Pharmaceutics
Sara Stocchetti, Ján Vančo, Jan Belza, Zdeněk Dvořák and Zdeněk Trávníček
{"title":"Strong in vitro anticancer activity of copper(ii) and zinc(ii) complexes containing naturally occurring lapachol: cellular effects in ovarian A2780 cells†‡","authors":"Sara Stocchetti, Ján Vančo, Jan Belza, Zdeněk Dvořák and Zdeněk Trávníček","doi":"10.1039/D4MD00543K","DOIUrl":null,"url":null,"abstract":"<p >Copper(<small>II</small>) and zinc(<small>II</small>) complexes with lapachol (HLap) of the composition [M(Lap)<small><sub>2</sub></small>(N–N)] and [Cu(Lap)(H<small><sub>2</sub></small>O)(terpy)]NO<small><sub>3</sub></small> (<strong>4</strong>), where M = Cu (<strong>1–3</strong>) or Zn (for <strong>5–7</strong>), and N–N stands for bathophenanthroline (<strong>1</strong> and <strong>5</strong>), 5-methyl-1,10-phenanthroline (<strong>2</strong> and <strong>6</strong>), 2,2′-bipyridine (<strong>3</strong>), 2,2′;6′,2′′-terpyridine (terpy, <strong>4</strong>) and 1,10-phenanthroline (<strong>7</strong>), were synthesised and characterised. Complexes <strong>1–5</strong> revealed strong <em>in vitro</em> antiproliferative effects against A2780, A2780R, MCF-7, PC-3, A549 and HOS human cancer lines and MRC-5 normal cells, with IC<small><sub>50</sub></small> values above 0.5 μM, and reasonable selectivity index (SI), with SI > 3.8 for IC<small><sub>50</sub></small>(MRC-5)/IC<small><sub>50</sub></small>(A2780). Considerable time-dependent cytotoxicity in A2780 cells was observed for complexes <strong>6</strong> and <strong>7</strong>, with IC<small><sub>50</sub></small> > 50 μM (24 h) to <em>ca.</em> 4 μM (48 h). Cellular effects of complexes <strong>1</strong>, <strong>5</strong> and <strong>7</strong> in A2780 cells were investigated by flow cytometry revealing that the most cytotoxic complexes (<strong>1</strong> and <strong>5</strong>) significantly perturbed the mitochondrial membrane potential and the interaction with mitochondrial metabolism followed by the triggering of the intracellular pathway of apoptosis.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 12","pages":" 4180-4192"},"PeriodicalIF":3.5970,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451940/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00543k","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Copper(II) and zinc(II) complexes with lapachol (HLap) of the composition [M(Lap)2(N–N)] and [Cu(Lap)(H2O)(terpy)]NO3 (4), where M = Cu (1–3) or Zn (for 5–7), and N–N stands for bathophenanthroline (1 and 5), 5-methyl-1,10-phenanthroline (2 and 6), 2,2′-bipyridine (3), 2,2′;6′,2′′-terpyridine (terpy, 4) and 1,10-phenanthroline (7), were synthesised and characterised. Complexes 1–5 revealed strong in vitro antiproliferative effects against A2780, A2780R, MCF-7, PC-3, A549 and HOS human cancer lines and MRC-5 normal cells, with IC50 values above 0.5 μM, and reasonable selectivity index (SI), with SI > 3.8 for IC50(MRC-5)/IC50(A2780). Considerable time-dependent cytotoxicity in A2780 cells was observed for complexes 6 and 7, with IC50 > 50 μM (24 h) to ca. 4 μM (48 h). Cellular effects of complexes 1, 5 and 7 in A2780 cells were investigated by flow cytometry revealing that the most cytotoxic complexes (1 and 5) significantly perturbed the mitochondrial membrane potential and the interaction with mitochondrial metabolism followed by the triggering of the intracellular pathway of apoptosis.
期刊介绍:
Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry.
In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.